Dr. Ronald P. Davis

Ophthalmology
Kaiser Foundation Health Plan Of The Northwest
10100 Se Sunnyside Rd, 
Clackamas, OR 
 (1840.0 mi)
Accepting New Patients
Kaiser Foundation Health Plan Of The Northwest
10100 Se Sunnyside Rd, 
Clackamas, OR 
 (1840.0 mi)
OverviewInsuranceLocationsClinical Research

Overview

Ronald Davis is an Ophthalmologist in Clackamas, Oregon. His top area of expertise is Vitrectomy. Dr. Davis is currently accepting new patients.

His clinical research consists of co-authoring 11 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Harvard Medical School
Specialties
Ophthalmology
Licenses
Ophthalmology in FL
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Kaiser

Locations

KAISER FOUNDATION HEALTH PLAN OF THE NORTHWEST
10100 Se Sunnyside Rd, Clackamas, OR 97015
Other Locations
KAISER FOUNDATION HEALTH PLAN OF THE NORTHWEST
12100 Se Stevens Ct, Suite 106, Portland, OR 97086
KAISER FOUNDATION HEALTH PLAN OF THE NORTHWEST
10180 Se Sunnyroad Rd, Clackamas, OR 97015

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
Enrollment Status: Completed
Publish Date: January 01, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients
A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients
Enrollment Status: Terminated
Publish Date: August 22, 2024
Intervention Type: Drug
Study Drug: JBPOS0101
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
Phase 1, Open-Label Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Phase 1, Open-Label Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Enrollment Status: Completed
Publish Date: April 04, 2024
Intervention Type: Drug
Study Drug: Carisbamate
Study Phase: Phase 1
Phase I, Open-Label, Pharmacokinetic, Dose Escalation Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Phase I, Open-Label, Pharmacokinetic, Dose Escalation Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Enrollment Status: Completed
Publish Date: May 30, 2023
Intervention Type: Drug
Study Drug: Carisbamate
Study Phase: Phase 1
View 4 Less Clinical Trials

11 Total Publications

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.
Journal: Epilepsia
Published: June 15, 2022
Similar Doctors
Expertise in
26
conditions
Dr. Mark E. Pennesi
Ophthalmology
Expertise in
26
conditions
Dr. Mark E. Pennesi
Ophthalmology

University Professional Services

3181 Sw Sam Jackson Park Rd, 
Portland, OR 
 (7.6 mi)
503-494-8311
Experience:
21+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Pennesi is an Ophthalmologist in Portland, Oregon. Dr. Pennesi has been practicing medicine for over 21 years is highly rated in 26 conditions, according to our data. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Retinitis Pigmentosa, Usher Syndrome, Late-Onset Retinal Degeneration, and Vitrectomy. Dr. Pennesi is currently accepting new patients.

Expertise in
20
conditions
Dr. Richard G. Weleber
Ophthalmology
Expertise in
20
conditions
Dr. Richard G. Weleber
Ophthalmology
3375 Sw Terwilliger Blvd, 
Portland, OR 
 (7.7 mi)
503-494-8386
Languages Spoken:
English

Richard Weleber is an Ophthalmologist in Portland, Oregon. Dr. Weleber is highly rated in 20 conditions, according to our data. His top areas of expertise are Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, Stargardt Macular Degeneration, and Usher Syndrome.

Expertise in
9
conditions
Dr. Justine R. Smith
Ophthalmology
Expertise in
9
conditions
Dr. Justine R. Smith
Ophthalmology
3375 Sw Terwilliger Blvd, 
Portland, OR 
 (7.7 mi)
503-494-5023
Languages Spoken:
English

Justine Smith is an Ophthalmologist in Portland, Oregon. Dr. Smith is highly rated in 9 conditions, according to our data. Her top areas of expertise are Ocular Toxoplasmosis, Uveitis, Toxoplasmosis, Scleritis, and Vitrectomy.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile